The hypoalgesic effect of tramadol in relation to CYP2D6

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 6, 1996, Pages 636-644

  Poulsen, Lars ^a   Arendt Nielsen, Lars ^b   Brøsen, Kim ^b   Sindrup, Søren H ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE RECEPTOR; PLACEBO; TRAMADOL;

ADULT; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG TOLERANCE; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLISM; NOCICEPTION; NORMAL HUMAN; PAIN; PHARMACODYNAMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; XEROSTOMIA;

ADULT; ANALGESICS, OPIOID; COLD; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP2D6; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PAIN; PAIN THRESHOLD; PRESSURE; REFERENCE VALUES; REFLEX; SPARTEINE; TRAMADOL;

EID: 0030471120     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90211-8     Document Type: Article

References (36)

1. Lee CR, McTavish D, Sorkin EM. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutical potential in acute and chronic pain. Drugs 1993;46:313-40.
2. Friderichs E, Felgenhauer F, Jongschaap P, Osterloh G. Pharmakologische Untersuchungen zur Analgesie, Abhängigkeits- und Toleranzentwicklung von Tramadol, einem stark wirkenden Analgetikum. Arzneimittelforschung 1978;28:122-34.
3. Frankus E, Friderichs E, Kim SM, Osterloh G. Über die Isomerentrennung, Strukturaufklärung und pharmakologische Charakterisierung von 1-(m-Methoxyphenyl)-2-(dimethylaminomethyl)-cyclohexan-1-ol. Arzneimittelforschung 1978;28:114-21.
4. Vogel W, Burchardi K, Sihler K, Valic L. Über die Wirkung von Tramadol auf Atmung und Kreislauf. Arzneimittelforschung 1978;28:183-6.
5. Vickers MD, O'Flaherty D, Szekely SM, Read M, Yoshizumi J. Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 1992;47:291-6.
6. Flohé L, Arend I, Cogal A, Richter W, Simon W. Klinische Prüfung der Abhängigkeitsentwicklung nach Langzeitapplikation von Tramadol. Arzneimittelforschung 1978;28:213-7.
7. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 1991;27:7-17.
8. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275-85.
9. Kayser V, Besson JM, Guilbaud G. Evidence for noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. Eur J Pharmacol 1992; 224:83-8.
10. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992;105:147-51.
11. Millan MJ. Multiple opioid systems and pain. Pain 1986;27:303-47.
12. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, et al. Complementary and synergistic antinociceptive interaction between enantiomers of tramadol. J Pharmacol Exp Ther 1993;267:331-40.
13. Lintz W, Erlancin S, Frankus E, Uragg H. Biotransformation of tramadol in man and animal, Artzneimittelforchung 1981;31:1932-43.
14. Paar WD, Frankus P, Dengler HJ. The metabolism of tramadol by human liver microsomes. Clin Invest 1992;70:708-10.
15. Alván G, Bechtel P, Iselius L, Gundert-Remy U. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur J Clin Pharmacol 1990;39:533-7.
16. Chen ZR, Somogyi AA, Bochner F. Polymorphic O-demethylation of codeine. Lancet 1988;2:914-5.
17. Dayer P, Desmeules J, Leemann T, Striberni R. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufl). Biochem Biophys Res Commun 1988;152:411-6.
18. Yue QY, Svensson JO, Aim C, Sjöqvist F, Säwe J. Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation. Br J Clin Pharmacol 1989;28:639-45.
19. Sindrup SH, Brøsen K, Bjerring P, Arendt-Nielsen L, Larson U, Angelo HR, et al. Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 1990;48:686-93.
20. Brøsen K, Otton SV, Gram LF. Sparteine oxidation polymorphism in Denmark. Acta Pharmacol Toxicol 1985;57:357-60.
21. Procacci P, Buzzell G, Passeri I, Sassi R, Voegelin MR, Zoppi M. Studies on the cutaneous pricking pain threshold in man. Circadian and circatrigintan changes. Res Clin Stud Headache 1972;3:260-76.
22. Poulsen L, Brøsen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol [in press].
23. Poulsen L, Arendt-Nielsen L, Brøsen K, Nielsen KK, Gram LF, Sindrup SH. The hypoalgesic effect of imipramine in different human experimental pain models. Pain 1995;60:287-93.
24. Brennum J, Kjeldsen M, Jensen K, Jensen TS. Measurements of human pressure-pain thresholds on fingers and toes. Pain 1989;38:211-7.
25. Jones SF, McQuay HJ, Moore RA, Hand CW. Morphine and ibuprofen compared using the cold pressor test. Pain 1988;34:117-22.
26. Becker R, Lintz W. Determination of tramadol in human serum by capillary gas chromatography with nitrogen-selective detection. J Chromatogr 1986;377: 213-20.
27. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5.
28. Campbell MJ, Gardner MJ. Calculating confidence intervals for some non-parametric analyses. Br Med J 1988;296:1454-6.
29. Otton SV, Inaba T, Kalow W. Competitive inhibition of sparteine oxidation in human liver by beta-adrenoreceptor antagonists and other cardiovascular drugs. Life Sci 1984;34:73-80.
30. Collart L, Luthy C, Favario-Constantin C, Dayer P. [Duality of the analgesic effect of tramadol in humans]. Schweiz Med Wochenschr 1993;47:2241-3.
31. Desmeules JA, Piquet V, Collart L, Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996;41:7-12.
32. Petersen-Felix S, Arendt-Nielsen L, Bak P, Bjerring P, Breivik H, Svensson P, et al. Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth 1994;73:326-30.
33. Sindrup SH. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic and -genetic aspects. Dan Med Bull 1994;41:66-78.
34. Sindrup SH. Antidepressants as analgesics. In: Biebuyck JF, Lynch C, Maze M, et al, editors. Anesthesia: biological foundations. New York: Raven Press [in press].
35. Dubner R. Pain and hyperalgesia following tissue injury: new mechanisms and new treatments. Pain 1991; 44:213-4.
36. Posner J. Pain models in healthy volunteers. In: Nimmo WS, Tucker G, editors. Clinical measurements in drug evaluation. London: Wolfe 1991:73-90.